Clinical ShowCase™ in aHUS: The Application of Complement Inhibitors in Practice
December 21, 2022
December 21, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Alexion Pharmaceuticals, Inc.
- Physicians — maximum of 0.25 AMA PRA Category 1 Credits™
- Nurses — 0.25 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed toward hematologists, nephrologists, primary care physicians, physician assistants, nurse practitioners, and nurses specializing in hematology and transplant medicine who may encounter patients with atypical hemolytic uremic syndrome (aHUS).
This online activity is designed to provide concise and easy-to-digest education in an engaging and interactive case-based format. The case focuses on diagnosing aHUS and choosing the most appropriate therapy based on the clinical scenario. The engaging format of this program includes interactive clinical decision points with explanations at the end of the activity and an evidence-based review supporting the teaching points covered in the case.
- Upon completion of this activity, participants should be better able to:
- Apply diagnostic criteria to patients with suspected aHUS
- Integrate clinical trial data on current and emerging complement inhibitors into the management of aHUS
Iberia Romina Sosa, MD, PhD
Fox Chase Cancer Center
Emily Walzer, MD
Medical Oncology and Hematology Fellow
Fox Chase Cancer Center
Temple University Health Systems
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.25 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Iberia Romina Sosa, MD, PhD, has no relevant financial relationships with ineligible companies.
Emily Walzer, MD, has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.